AAP IMPLANTATE AG

Communiqués aap Implantate AG Deutsche Boerse AG

Actions

AAQ

DE0005066609

Cours en clôture Deutsche Boerse AG Autres places de cotation 00:00:00 05/02/2024			Varia. 5j.	Varia. 1 janv.
0,66 ^EUR	-9,59 %		-5,71 %	-10,20 %

2021	Aap Implantate Ag annonce ses résultats pour l'exercice complet clos le 31 décembre 2020.	CI
2021	Aap Implantate AG fournit des prévisions de bénéfices pour l'année 2021	CI

Communiqués

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Aap Implantate AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution	06/06	EQ
NVR: aap Implantate AG: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution	31/05	EQ
Amendment of the terms and conditions of the bond completed; Bondholders can convert bonds into shares	23/05	EQ
Aap Implantate AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution	22/04	EQ
Aap closes Q1 2024 with sales growth of 5.6% and positive developments at all operating levels and makes a strong start to Q2 2024	22/04	EQ
NVR: aap Implantate AG: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution	19/04	EQ
Aap successfully places a 10% capital increase from authorized capital at EUR 1.10 with exclusion of subscription rights	19/04	EQ
Aap Implantate AG: aap postpones publication of the consolidated financial statements 2023 due to staff shortages	17/04	EQ
Aap 100% approval of the proposed resolution to amend the terms and conditions of the mandatory convertible bond 2023/2028	03/04	EQ
Aap Implantate AG: Capital increase from authorized capital with exclusion of subscription rights	18/03	EQ
Aap proposes to the bondholders of the mandatory convertible bond 2023/2028 an amendment to the bond terms and conditions to enable the bondholders to exercise their conversion rights earlier	05/03	EQ
After a mixed 2023 financial year, aap makes a strong start to the 2024 financial year	15/02	EQ
Aap Implantate : with positive EBITDA in Q2 and H1/2021 for first time since focusing on trauma and significant sales growth of +74% (Q2) and +37% (H1)	13/08/21	PU
Aap Implantate : with positive EBITDA in Q2 and H1/2021 for first time since focusing on trauma and significant sales growth of +74% (Q2) and +37% (H1)	13/08/21	EQ
Q1/21: Successful start to the year with sales growth (+9%) and significant earnings improvement (+91%) despite still burdening COVID-19 pandemic - restructuring successes clearly visible	28/05/21	EQ
2020 financial statements: visible results under restructuring with significantly improved Recurring EBITDA (+28%) in challenging times of COVID-19 pandemic	30/04/21	EQ
Q1/2021: Solid start to year with 9% sales growth despite still burdening COVID 19 pandemic; more than 500 surgeries in US mark new high; Q2 order book well filled	26/04/21	EQ
Aap Implantate : Publication of annual financial statements 2020 on 30 April 2021	10/03/21	EQ
FY/2020: Sales of EUR 9.3 million in Corona year in upper half of guidance - dynamic sales growth in USA (+41%); significant sales growth and positive EBITDA in trauma business planned for FY/2021	21/01/21	EQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Nos Contenus Gratuits vous Aident à Sécuriser et Augmenter la Performance de vos Investissements

Sécuriser mes Investissements

fermer